Cvs Health (CVS) Notes Payables (2009 - 2025)

Cvs Health has reported Notes Payables for 16 years, with the latest figure at $1.2 billion in Q3 2025.

• For the quarter ending Q3 2025, Notes Payables rose 55.88% year-over-year to $1.2 billion; the trailing twelve-month figure through Sep 2025 stood at $1.2 billion (up 55.88% YoY), and the FY2024 full-year result was $2.1 billion, up 959.5% from the prior year.
• Notes Payables for Q3 2025 stood at $1.2 billion, down from $3.0 billion in the prior quarter.
• The five-year high for Notes Payables was $3.0 billion in Q2 2025, with the low at $200.0 million in Q4 2023.
• Historically, Notes Payables has averaged $1.4 billion across 4 years, with a median of $1.2 billion in 2025.
• Annual changes were most pronounced in 2024 — Notes Payables jumped 959.5% — and 2025, when it slumped 53.7%.
• Cvs Health's Notes Payables stood at $252.0 million in 2021, then declined by 20.63% to $200.0 million in 2023, then jumped by 959.5% to $2.1 billion in 2024, then slumped by 41.15% to $1.2 billion in 2025.
• The last three Notes Payables figures came in at $1.2 billion (Q3 2025), $3.0 billion (Q2 2025), and $1.3 billion (Q1 2025), per Business Quant data.